Probi AB (publ)

PBBIF

PBBIFProbi AB (publ) US flag

Other OTC

24.00

USD

- -

0.09EPS

266.67P/E

286.93MMarket Cap

Feb 28Next Earn

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

SE0001280355

Return %

Stock

S&P500

41.18

10.92

-47.37

26.22

71.43

120.31

Use logarithmic scale

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	9.73	10.39	10.72	14.03	22.36	46.71	53.73	53.02	54.96	62.94	57.76	54.26	55.09	55.33
Basic EPS, GAAP	1.45	1.4	1.56	2.25	5.08	10.73	6.06	6.69	7.54	8.14	7.3	3.57	1.48	0.96
Free Cash Flow per Basic Share	0.74	1.83	1.12	2.44	4.41	7.53	10.48	9.99	12.15	8.78	9.8	8.03	2.75	6.69
Dividend per Share	0.94	0.71	0.71	0.71	0.8	0.96	1	- -	- -	1	1.1	1.3	1.3	1.3
Book Value per Share	4.57	5.3	6.86	8.41	12.68	28.45	28.78	35.47	43.16	50.29	56.49	58.75	58.93	- -
Tangible Book Value per Share	10.01	10.78	10.64	12	14.87	2.52	10.27	20.18	31.08	38.73	50.48	59.17	60.4	62.07
Basic Weighted Avg Shares	10	10	10	10	10	9	11	11	11	11	11	11	11	11
Sales/Revenue/Turnover	95	100	104	136	216	443	612	604	626	717	658	618	628	630
Operating Margin (%)	21.55	17.14	17.52	21.11	27.02	27.05	17	16.74	17.81	17.25	16.6	8.18	1.8	0.49
Depreciation Expense	9	6	5	9	6	33	53	54	72	73	73	86	96	101
Net Income, GAAP	14	14	15	22	49	102	69	76	86	93	83	41	17	11
Effective Tax Rate (%)	27.23	26.29	22.81	22.52	22.27	19.6	25.16	22.64	21.58	22.81	22.61	21.84	3.24	12.29
Profit Margin (%)	14.94	13.45	14.53	16.05	22.71	22.97	11.29	12.62	13.72	12.92	12.63	6.57	2.68	1.73
Working Capital	94	102	101	111	139	-20	84	206	292	324	388	454	462	472
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	47	31	63	54	38	61
Total Equity	116	123	131	146	187	892	885	1,028	1,152	1,115	1,266	1,411	1,369	1,368
Return on Invested Capital (%)	12.43	10.59	10.98	15.79	27.03	14.78	7.15	7.09	7.38	8.01	6.75	2.8	0.75	- -
Return on Capital (%)	37.88	28.19	25.6	29.51	48.16	33.56	14.69	15.68	16.4	16.09	12.63	5.82	2.56	5.01
Return on Common Equity (%)	37.87	28.19	25.6	29.51	48.14	51.87	23.11	20.83	19.17	17.41	13.67	6.19	2.51	3.23

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	23.77%	1.08%	1.52%
Net Income, GAAP	15.64%	-19.9%	-58.6%
Free Cash Flow	24.98%	-15.65%	-65.72%
Total Cash Common Dividend	- -	- -	- -
Total Equity	46.24%	6.17%	-2.94%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Ms. Anita Johansen
Full Time Employees: 157
Sector: Healthcare
Industry: Biotechnology
Address: Ideongatan 1A Lund Sweden 223 70
IPO Date: Oct 17, 2016
Website: probi.com
Similar Companies: International Stem Cell Corporation (ISCO)
Pharma Mar, S.A. (0RC6.L)
Frequency Therapeutics, Inc. (FREQ)
Adynxx, Inc. (ADYX)
MediciNova, Inc. (4875.T)
RVL Pharmaceuticals plc (RVLPQ)
Business: Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.

	Mar'24	Jun'24	Sep'24
ST Debt	15	21	20
LT Borrowings	- -	- -	- -
LT Finance Leases	37	68	61
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	11	11	11
Market Capitalization	1,942	2,330	2,790

	Mar'24	Jun'24	Sep'24
Total Current Assets	553	563	562
Accounts Receivable, Net	71	115	63
Cash, Cash Equivalents & STI	340	305	349
Inventories	127	126	129
Total Current Liabilities	69	93	90
Payables & Accruals	- -	- -	- -
ST Debt	15	21	20
Deferred Revenue	- -	- -	- -

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	TTM
Revenue per Share	9.73	10.39	10.72	14.03	22.36	46.71	53.73	53.02	54.96	62.94	57.76	54.26	55.09	55.33
Basic EPS, GAAP	1.45	1.4	1.56	2.25	5.08	10.73	6.06	6.69	7.54	8.14	7.3	3.57	1.48	0.96
Free Cash Flow per Basic Share	0.74	1.83	1.12	2.44	4.41	7.53	10.48	9.99	12.15	8.78	9.8	8.03	2.75	6.69
Dividend per Share	0.94	0.71	0.71	0.71	0.8	0.96	1	- -	- -	1	1.1	1.3	1.3	1.3
Book Value per Share	4.57	5.3	6.86	8.41	12.68	28.45	28.78	35.47	43.16	50.29	56.49	58.75	58.93	- -
Tangible Book Value per Share	10.01	10.78	10.64	12	14.87	2.52	10.27	20.18	31.08	38.73	50.48	59.17	60.4	62.07
Basic Weighted Avg Shares	10	10	10	10	10	9	11	11	11	11	11	11	11	11
Sales/Revenue/Turnover	95	100	104	136	216	443	612	604	626	717	658	618	628	630
Operating Margin (%)	21.55	17.14	17.52	21.11	27.02	27.05	17	16.74	17.81	17.25	16.6	8.18	1.8	0.49
Depreciation Expense	9	6	5	9	6	33	53	54	72	73	73	86	96	101
Net Income, GAAP	14	14	15	22	49	102	69	76	86	93	83	41	17	11
Effective Tax Rate (%)	27.23	26.29	22.81	22.52	22.27	19.6	25.16	22.64	21.58	22.81	22.61	21.84	3.24	12.29
Profit Margin (%)	14.94	13.45	14.53	16.05	22.71	22.97	11.29	12.62	13.72	12.92	12.63	6.57	2.68	1.73
Working Capital	94	102	101	111	139	-20	84	206	292	324	388	454	462	472
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	47	31	63	54	38	61
Total Equity	116	123	131	146	187	892	885	1,028	1,152	1,115	1,266	1,411	1,369	1,368
Return on Invested Capital (%)	12.43	10.59	10.98	15.79	27.03	14.78	7.15	7.09	7.38	8.01	6.75	2.8	0.75	- -
Return on Capital (%)	37.88	28.19	25.6	29.51	48.16	33.56	14.69	15.68	16.4	16.09	12.63	5.82	2.56	5.01
Return on Common Equity (%)	37.87	28.19	25.6	29.51	48.14	51.87	23.11	20.83	19.17	17.41	13.67	6.19	2.51	3.23

Year	Q1	Q2	Q3	Q4	FY
2022	155	175	145	144	618
2023	172	144	156	156	628
2024	152	179	144	- -	- -

Year	Q1	Q2	Q3	Q4	FY
2022	1.23	1.75	1.09	- -	3.57
2023	1.69	-0.55	0.56	- -	1.48
2024	0.16	0.71	0.31	- -	- -

Probi AB (publ)

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year